News Archives - Page 60 of 94

TuesdayFeb 28, 2023 11:28 am

TinyGemsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Releases Progress Updates on Two Clinical Development Programs

Cybin (NEO: CYBN) (NYSE American: CYBN),a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(TM), is reporting on its two lead clinical development programs: CYB003, a proprietary deuterated psilocybin analog for the potential treatment of major depressive disorder (“MDD”), and CYB004, a proprietary deuterated N,N-dimethyltryptamine molecule being developed for the potential treatment of generalized anxiety disorder (“GAD”). According to the announcement, interim data from the CYB003 phase 1/2a study exhibited rapid and short-acting effects; strong psychedelic effects at low doses; and a positive safety and tolerability profile. The company anticipates having top-line efficacy data by late Q3 2023. In addition, initial findings…

MondayFeb 27, 2023 3:07 pm

TinyGemsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Autonomous Robots, Cutting-Edge Technology Covered by Benzinga

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”) and blue light emergency communication systems, was featured in recent video coverage by Benzinga. “Knightscope is making the U.S. the safest country in the world with autonomous robots and cutting-edge technology that innovates public safety and fights crime,” as reported by Benzinga. “Knightscope robots are designed to provide security levels that allow them to deter, detect and report security risks. Lights and noise deter criminals in their tracks and prevent a crime before it starts. They can detect 90 terabytes of data per year that no human being can…

FridayFeb 24, 2023 3:11 pm

TinyGemsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Adds KAP Reseller, Secures New Contracts

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”) and blue light emergency communication systems, today announced its entry into an agreement with GPI Defense, a Houston based provider of custom tailored security services, to join the company’s reseller program as a Knightscope Authorized Partner (“KAP”). In addition, GPI Defense signed a contract for two K5s and a pre-order for two K1-Hemisphere ASRs, and Knightscope secured another pre-order sales agreement with a large health care group in the Midwest and a full-service agreement with a Southern California university. “Knightscope and GPI Defense are aligned to protect the places…

ThursdayFeb 23, 2023 1:00 pm

TinyGemsBreaks – Golden Matrix Group Inc. (NASDAQ: GMGI) Releases Q1 Financial Report with Record $10.5M Revenues

Golden Matrix Group (NASDAQ: GMGI), a developer, licensor and global operator of online gaming and eCommerce platforms, systems, and gaming content, is reporting record revenues for its first quarter, ending Jan. 31, 2023. The report shows that revenues reached more than $10.5 million for the quarter, an estimated 19% improvement on $8.8 million revenues for the same quarter last year and a 10% increase over $9.57 million revenues for the previous quarter. Additional financial results for the quarter will be available in GMGI’s quarterly report on 10-Q filing, which should be filed on or before March 15, 2023. “Our new…

ThursdayFeb 23, 2023 10:03 am

TinyGemsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Announces Plan to Streamline Efforts, Maximize Efficiency, Focus on Clinical Trials

Cybin (NEO: CYBN) (NYSE American: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(TM), has announced a strategic plan designed to streamline efforts, maximize operating efficiency and focus on critical clinical trials, including near-term, mid-term and long-term milestones. A part of that plan was the release of an estimated 15% of Cybin’s workforce, including those in roles that were identified as not a clinical priority or not directly involved with any clinical trial initiatives. This move alone is expected to generate cost savings by reducing operating expenses. The announcement noted that with the anticipated cost savings from the overall streamlining…

TuesdayFeb 21, 2023 12:39 pm

TinyGemsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Releases Findings from Hypertension Study

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, is reporting additional findings from its human clinical study HYPER-H21-4; the study is designed to demonstrate a potentially novel mechanism of action of LEXX’s patented DehydraTECH-processed cannabidiol ("CBD") capsule formulation in the treatment of blood pressure ("BP"). According to the announcement, Lexaria believes that those findings, which were published in the peer-reviewed “Biomedicine and Pharmacotherapy" journal, could support DehydraTECH-CBD qualification within existing Food and Drug Administration (“FDA”) guidelines. Previous results of the study indicated that primary efficacy and safety objectives were successfully achieved, including hypertensive patients seeing resting blood pressure…

TuesdayFeb 21, 2023 10:55 am

TinyGemsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Builds on Growing Success with Sales of New K1 Call Boxes

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots and blue light emergency communication systems, sees continued growth through sales of 11 K1 Call Boxes to Larimer County, Colorado. The transaction was completed through KSCP resale partner Stream Speed Technologies (“SST”). Knightscope’s smallest emergency call box system, the K1 Call Box, offers one-touch connection with a ruggedized housing and simple interface. The call box offers a completely wireless solution for emergency phone calls and can also work with existing nearby wiring nearby. In addition, the system includes additional options that allow people who are deaf, hard of hearing or…

TuesdayFeb 21, 2023 10:38 am

TinyGemsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Releases Q2 2023 Financial, Corporate Report

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, is reporting on its second quarter of fiscal year 2023, the period that ended Dec. 31, 2022. Highlights of the report include the company closing the calendar year with nearly $11.5 million in cash and the completion of enrollment in the company’s phase 2 clinical trial in epidermolysis bullosa (“EB”). The report also noted that the company has seen advancement in its research using rare cannabinoids in the treatment of glaucoma and neurodegenerative diseases such as Alzheimer’s, Huntington’s and Parkinson’s. “This…

ThursdayFeb 16, 2023 11:30 am

TinyGemsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Launches Major Fr8TMS Update

Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”) is a technology company whose custom-developed Fr8App is an industry-leading freight-matching platform powered by AI and machine-learning and offers a real-time portal for B2B cross-border shipping and domestic shipping within the USMCA region. The company today announced the launch of a major update for its transportation management system (“Fr8TMS”). The new update is designed to transform the commercial trucking industry by introducing logistics and transportation technology to move freight within the USMCA region, with a focus on cross-border shipping. “We are excited to introduce this new update to the Fr8TMS, which will revolutionize the commercial…

WednesdayFeb 15, 2023 12:04 pm

TinyGemsBreaks – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Completes Strategic Sale of Alta Mesa Project

Energy Fuels (NYSE American: UUUU) (TSX: EFR) today announced its completion of the sale of three wholly owned subsidiaries that together hold its Alta Mesa ISR Project to enCore Energy Corp. “Energy Fuels’ sale of the Alta Mesa project for $120 million of total consideration is highly strategic for a variety of reasons,” said UUUU CEO and President Mark S. Chalmers. “When combined with our already strong balance sheet, the proceeds from this sale are expected to fully fund our current uranium, vanadium and rare earth business plans through approximately 2024 without the dilution to shareholders one might normally expect,…

Spotlighting undiscovered companies with enormous upside potential.

Contact us: (512) 354-7000

Breaks Categories: News